<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Fatima A</submitter><funding>Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico</funding><funding>BLRD VA</funding><funding>Office of Dietary Supplements</funding><funding>NCCIH NIH HHS</funding><funding>University of North Texas</funding><funding>National Center for Complementary and Integrative Health</funding><funding>U.S. Department of Veterans Affairs</funding><pagination>8222-8330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6590917</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(5)</volume><pubmed_abstract>Bioactive dietary polyphenols have health benefits against a variety of disorders, but some benefits of polyphenols may be not directly related to them, but rather to their metabolites. Recently, we have identified the brain-available phenol glucuronide metabolite deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-glucuronide (&lt;b>5&lt;/b>) in perfused rat brains following sub-acute treatment with the stilbene resveratrol (&lt;b>1&lt;/b>). However, the role of such a metabolite in the neuroprotective activity of resveratrol (&lt;b>1&lt;/b>) is not understood, in part due to the non-commercial availability of &lt;b>5&lt;/b> for performing biological evaluation in animal models of Alzheimer's disease or other neurological disorders. Here, we describe a concise chemical synthesis of deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-</pubmed_abstract><journal>ACS omega</journal><pubmed_title>An Efficient Synthesis of Deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-glucuronide, a Brain-targeted Derivative of Dietary Resveratrol, and its Precursor 4'-&lt;i>O&lt;/i>-Me-Resveratrol.</pubmed_title><pmcid>PMC6590917</pmcid><funding_grant_id>P50 AT008661-01</funding_grant_id><funding_grant_id>IK6 BX003785</funding_grant_id><funding_grant_id>204106/2017-6</funding_grant_id><funding_grant_id>P50 AT008661</funding_grant_id><pubmed_authors>Docampo-Palacios M</pubmed_authors><pubmed_authors>Alvarez-Hernandez A</pubmed_authors><pubmed_authors>de Fatima A</pubmed_authors><pubmed_authors>Pasinetti GM</pubmed_authors><pubmed_authors>Dixon RA</pubmed_authors></additional><is_claimable>false</is_claimable><name>An Efficient Synthesis of Deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-glucuronide, a Brain-targeted Derivative of Dietary Resveratrol, and its Precursor 4'-&lt;i>O&lt;/i>-Me-Resveratrol.</name><description>Bioactive dietary polyphenols have health benefits against a variety of disorders, but some benefits of polyphenols may be not directly related to them, but rather to their metabolites. Recently, we have identified the brain-available phenol glucuronide metabolite deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-glucuronide (&lt;b>5&lt;/b>) in perfused rat brains following sub-acute treatment with the stilbene resveratrol (&lt;b>1&lt;/b>). However, the role of such a metabolite in the neuroprotective activity of resveratrol (&lt;b>1&lt;/b>) is not understood, in part due to the non-commercial availability of &lt;b>5&lt;/b> for performing biological evaluation in animal models of Alzheimer's disease or other neurological disorders. Here, we describe a concise chemical synthesis of deoxyrhapontigenin-3-&lt;i>O&lt;/i>-&lt;i>β&lt;/i>-D-</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2025-04-04T21:00:41.927Z</modification><creation>2019-07-24T07:27:22Z</creation></dates><accession>S-EPMC6590917</accession><cross_references><pubmed>31236526</pubmed><doi>10.1021/acsomega.9b00722</doi></cross_references></HashMap>